Androgen deprivation therapy is widely used in a number of different settings in the treatment of prostate cancer. This overview will look at the current evidence for the potential development of metabolic syndrome and cardiovascular disease as a consequence of this therapy, and highlight strategies aimed at their prevention. The relationship between metabolic syndrome and prostate cancer development will also be examined.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.clon.2008.11.013 | DOI Listing |
Publication Analysis
Top Keywords
metabolic syndrome
12
prostate cancer
12
syndrome prostate
8
cancer review
4
review androgen
4
androgen deprivation
4
deprivation therapy
4
therapy number
4
number settings
4
settings treatment
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!